The biology of cytomegalovirus drug resistance

Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation

(2013) Scott M. Palmer   ANNALS OF INTERNAL MEDICINE

First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246

(2011) D. R. Kaul et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Recombinant Phenotyping of Cytomegalovirus UL54 Mutations That Emerged during Cell Passages in the Presence of either Ganciclovir or Foscarnet

(2011) Christian Gilbert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir

(2011) David Boutolleau et al.   ANTIVIRAL RESEARCH

Antiviral Inhibition Targeting the HCMV Kinase pUL97 Requires pUL27-Dependent Degradation of Tip60 Acetyltransferase and Cell-Cycle Arrest

(2011) Justin M. Reitsma et al.   Cell Host & Microbe

Cytomegalovirus: pathogen, paradigm, and puzzle

(2011) Michael Boeckh et al.   JOURNAL OF CLINICAL INVESTIGATION

Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus

(2011) Clara C. Posthuma et al.   JOURNAL OF CLINICAL VIROLOGY

Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy

(2011) Sunwen Chou   JOURNAL OF CLINICAL VIROLOGY

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

(2011) T. Goldner et al.   JOURNAL OF VIROLOGY

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

(2011) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients

(2011) Hans-Arne Myhre et al.   TRANSPLANTATION

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

(2010) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246

(2010) P. Lischka et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Recombinant Phenotyping of Cytomegalovirus UL97 Kinase Sequence Variants for Ganciclovir Resistance

(2010) S. Chou   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Stereoselective Phosphorylation of Cyclopropavir by pUL97 and Competitive Inhibition by Maribavir

(2010) B. G. Gentry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Differentiation between Polymorphisms and Resistance-Associated Mutations in Human Cytomegalovirus DNA Polymerase

(2010) M. Chevillotte et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cytomegalovirus UL97 Mutations Affecting Cyclopropavir and Ganciclovir Susceptibility

(2010) Sunwen Chou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Improved Detection of Mutated Human Cytomegalovirus UL97 by Pyrosequencing

(2010) B. Schindele et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

(2010) S. Hantz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene

(2010) Mélanie Martin et al.   JOURNAL OF CLINICAL VIROLOGY

Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis

(2010) Mélanie Martin et al.   JOURNAL OF CLINICAL VIROLOGY

Virologic Characterization of Multidrug‐Resistant Cytomegalovirus Infection in 2 Transplant Recipients Treated with Maribavir

(2010) Lynne Strasfeld et al.   JOURNAL OF INFECTIOUS DISEASES

Deep Sequencing Reveals Highly Complex Dynamics of Human Cytomegalovirus Genotypes in Transplant Patients over Time

(2010) I. Gorzer et al.   JOURNAL OF VIROLOGY

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

(2010) R.K. Avery et al.   Transplant Infectious Disease

Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients

(2010) J.M. Iwasenko et al.   Transplant Infectious Disease

Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance

(2010) Martha T. van der Beek et al.   TRANSPLANTATION

Recombinant Phenotyping of Cytomegalovirus Sequence Variants Detected After 200 or 100 Days of Valganciclovir Prophylaxis

(2010) Sunwen Chou et al.   TRANSPLANTATION

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

(2010) Camille N. Kotton et al.   TRANSPLANTATION

The search for new therapies for human cytomegalovirus infections

(2010) Mark N. Prichard et al.   VIRUS RESEARCH

Development of CMX001 for the Treatment of Poxvirus Infections

(2010) Randall Lanier et al.   Viruses-Basel

Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir

(2009) Mark N. Prichard   REVIEWS IN MEDICAL VIROLOGY

Diverse Cytomegalovirus UL27 Mutations Adapt to Loss of Viral UL97 Kinase Activity under Maribavir

(2008) S. Chou   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY